Miguel Forte

Miguel Forte serves as the Chief Executive Officer of Kiji Therapeutics, focusing on the development of innovative engineered cell therapies for critical diseases. Additionally, Miguel holds multiple leadership roles within the International Society for Cell & Gene Therapy (ISCT), including President and Vice-Chair of the Ethics Committee, advocating for ethical practices and the global advancement of cell and gene therapies. As a founder and Managing Director of modified Cell for Therapeutics (mC4Tx), Miguel consults on business strategy and regulatory pathways in biotech. With extensive experience in various organizations, Miguel has also contributed to the Alliance for Regenerative Medicine and has served in executive capacities at Bone Therapeutics and stem cell-related initiatives. Miguel's academic credentials include an MD, a PhD in Immunology, and professional qualifications in Tropical Medicine and Pharmaceutical Medicine.